Qatar's Ministry of Public Health registers every medicine through its Pharmacy and Drug Control Department before it can be imported or sold.

One ministry regulates medicines in Qatar, through one working department

The Ministry of Public Health (MOPH) is Qatar's medicines regulator. It has held that role since 2016, when the Emir disbanded the Supreme Council of Health and folded its functions back into MOPH.

Inside MOPH, the working unit for medicines is the Pharmacy and Drug Control Department (PDCD). PDCD reviews and approves marketing authorisation applications for finished pharmaceutical products, licenses drug stores and pharmacists, and runs its own PDCD E-System portal for electronic submissions, including eCTD dossiers.

No medicine can legally be marketed, imported, or distributed in Qatar until PDCD has approved it under a named local marketing authorisation holder. That single point of control is worth understanding before an Indian supplier commits to a Qatar order, whether the buyer is a hospital, a wholesaler, or a private pharmacy chain.

A foreign medicine needs a Qatar-based marketing authorisation holder before PDCD will register it

An Indian manufacturer, or M Care Exports acting as its export partner, cannot register a product in Qatar directly. PDCD requires a Qatar-registered local agent to act as marketing authorisation holder (MAH): the entity that submits the dossier, holds the approval once granted, and answers for later variations and pharmacovigilance reporting.

The registration file follows the CTD structure and is submitted electronically through the PDCD E-System. It needs a legalised, valid Good Manufacturing Practice (GMP) certificate and manufacturing licence from the health authority in the product's country of origin, stability and analytical data, and Arabic-language labelling and patient information.

Building that file correctly the first time matters more in Qatar than in most markets, because PDCD works from a fixed CTD structure and does not iterate informally on a rejected submission. See how M Care Exports prepares a CTD dossier for exactly this kind of filing.

Registering the product is not the same as being licensed to import it

Product registration and import licensing are two separate approvals in Qatar. Once PDCD has approved a medicine, only a licensed Qatari entity may actually bring it into the country and distribute it. Under PDCD's published importer conditions, that entity needs:

• a valid Drug Store licence, issued by PDCD's inspection function
• a valid Pharmacist licence, issued by MOPH
• a Commercial Registration from the Ministry of Commerce and Industry that names trading in medicines as a permitted activity

Controlled and narcotic-classed drugs carry extra conditions on top of this standard route, with additional approvals and handling rules that go beyond a routine consignment. An Indian exporter should confirm the current requirements for any scheduled product with the Qatar-side importer before committing to a shipment.

For an Indian exporter, this means the buyer or agent on the Qatar side has to hold current licences in their own name, not just a registered product. M Care Exports checks an importer's licensing status as a standard step before confirming an order.

GCC central registration can shorten Qatar's review, it does not replace it

Qatar takes part in the Gulf Health Council's central registration system, the regional mechanism that lets a pharmaceutical product be reviewed once for multiple GCC member states rather than filed separately in each. The Council runs this as its Central Registry for human medicines, medical devices, and veterinary medicines.

Where a product already holds a valid, GCC-executive-office-stamped central registration certificate, PDCD offers a faster assessment track for the Qatar filing, provided the applicant submits that certificate and confirms the product information matches the GCC-approved version exactly.

That fast-track shortens Qatar's own review; it does not substitute for it. The national requirements still apply in full: a Qatar-registered local agent, Arabic labelling, and PDCD's own approval before the product can be marketed or imported. For the broader question of when a regional pathway actually speeds up a national filing, see our note on WHO prequalification versus national registration.

Hamad Medical Corporation is Qatar's largest pharmaceutical buyer, and it tenders only to registered vendors

Hamad Medical Corporation (HMC) runs Qatar's public hospital network on a shared formulary, managed centrally by its Supply Chain Management division. HMC sources medicines through periodic tenders and standing or blanket purchase agreements for formulary lines, plus ad hoc emergency procurement to cover shortages.

A supplier cannot bid without first completing HMC's own vendor registration, credentialed to the relevant product category for pharmaceuticals. Every drug quotation submitted through HMC's e-tendering platform must carry a valid MOPH registration certificate for that specific product, while implants carry their own separate registration requirement.

Shipment conditions are exacting. Controlled and narcotic drugs need copies of the supplier's valid import and supply licences attached, biologic products such as those derived from human blood or plasma typically carry an additional certification requirement from the country-of-origin regulator, and standard shipping paperwork, legalised where required, has to accompany every delivery. M Care Exports builds tender responses and shipment files against these HMC-specific conditions rather than a generic export template. See our tender response support, and the wider Qatar market page for buyer-by-buyer detail.

The Indian half of the file has to match what PDCD and HMC actually ask for

For a shipment from India, the document pack an exporter assembles typically includes:

• a WHO-GMP certificate for the manufacturing site, where the product is a generic sourced from a WHO-GMP certified Indian plant, or the relevant manufacturing and marketing authorisation where the product is an originator brand moved through licensed Indian channels
• a Certificate of Pharmaceutical Product (CPP) in WHO format, issued by India's Central Drugs Standard Control Organisation
• a batch-wise Certificate of Analysis
• a Certificate of Origin from an Indian Chamber of Commerce
• a commercial invoice and packing list matching the product, quantities, and HS codes on the shipment exactly

Because both Qatar Customs and HMC call for legalised paperwork, and Qatar is not a party to the Hague Apostille Convention, the Certificate of Origin and invoice typically need attestation through the Qatar Embassy in India, or through India's Ministry of External Affairs and Qatar's Ministry of Foreign Affairs where no consulate covers the shipment.

M Care Exports has supplied 49 markets since 2003 and builds this pack against each product's actual manufacturer file, not a standard template, because PDCD and HMC both reject documentation that does not match the registered product exactly. Buyers evaluating a specific molecule can start with a medicine request or open a trade account to move straight to sourcing.

Frequently asked

Which authority registers medicines in Qatar?

Qatar's Ministry of Public Health (MOPH) is the country's medicines regulator. Registration is handled by MOPH's Pharmacy and Drug Control Department (PDCD), which reviews and approves marketing authorisation applications, licenses drug stores and pharmacists, and runs its own PDCD E-System portal for electronic and eCTD submissions. No medicine may legally be marketed, imported, or distributed in Qatar until PDCD has approved it under a named local marketing authorisation holder.

Can an Indian manufacturer sell directly into Qatar without a local partner?

No. PDCD requires every product to have a Qatar-registered marketing authorisation holder, and separately, the entity that physically imports and distributes the product needs its own Drug Store licence, a Pharmacist licence, and a Commercial Registration from the Ministry of Commerce and Industry naming medicines trading as a permitted activity. In practice, an Indian exporter works through a licensed Qatari importer or agent. M Care Exports prepares the Indian-side dossier and shipment documentation that partner needs to take the product through PDCD and, where relevant, through Hamad Medical Corporation's tender process.

Does GCC central registration mean a product is automatically approved in Qatar?

Not automatically. Qatar takes part in the Gulf Health Council's central registration system, and PDCD offers a faster assessment track for products holding a valid, GCC-executive-office-stamped central registration certificate. The applicant still has to submit that certificate and confirm the product information matches the GCC-approved version exactly. What it does not remove is the national file: a Qatar-registered local agent, Arabic labelling, and PDCD's own approval are all still required before the product can be marketed or imported into Qatar.

How does Hamad Medical Corporation buy medicines?

Hamad Medical Corporation runs Qatar's largest public hospital network on a shared formulary, managed centrally by its Supply Chain Management division. It buys through periodic tenders, standing and blanket purchase agreements for formulary lines, and ad hoc emergency procurement to cover shortages. A supplier has to complete HMC's own vendor registration and hold pharmaceutical credentialing before it can bid, and every drug quotation submitted through HMC's e-tendering platform must carry a valid MOPH registration certificate for that specific product.

What documents does an Indian exporter need to prepare for Qatar?

The pack typically includes a WHO-GMP certificate for the manufacturing site for a generic, or the relevant Indian manufacturing and marketing authorisation for an originator brand, a WHO-format Certificate of Pharmaceutical Product from India's Central Drugs Standard Control Organisation, a batch-wise Certificate of Analysis, a Certificate of Origin, and a commercial invoice and packing list, usually legalised through the Qatar Embassy in India. M Care Exports assembles this against the actual manufacturer file for each product, because PDCD and Hamad Medical Corporation both reject documentation that does not match the registered product.

Is it worth registering a product in Qatar for a small order?

Registration is a national requirement, not a per-order one, so it only pays for itself against volume a buyer can commit to, typically a hospital network or a licensed wholesale importer with an ongoing formulary need, rather than a single trial shipment. Many Indian suppliers start by responding to a Hamad Medical Corporation tender, or an importer's request for a molecule that is already registered in Qatar, then build toward registering additional products once demand is established.